Kiri
| Dokumendiregister | Majandus- ja Kommunikatsiooniministeerium |
| Viit | 6-4/1711-1 |
| Registreeritud | 20.06.2024 |
| Sünkroonitud | 21.06.2024 |
| Liik | Sissetulev kiri |
| Funktsioon | 6 Rahvusvahelise koostöö korraldamine |
| Sari | 6-4 Tervitus- ja tutvustuskirjad, kutsed üritustel osalemiseks |
| Toimik | 6-4/2024 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | RLT Academy |
| Saabumis/saatmisviis | RLT Academy |
| Vastutaja | Silver Tammik (Majandus- ja Kommunikatsiooniministeerium, Kantsleri valdkond, Strateegia ja teenuste juhtimise valdkond, EL ja rahvusvahelise koostöö osakond) |
| Originaal | Ava uues aknas |
Failid
On behalf of the Radioligand Therapy (RLT) Academy Consortium (Erasmus+ Project), we are thrilled to announce the upcoming launch of the RLT Academy Policy Recommendations. This significant event which will serve as the closing of the RLT first edition is scheduled for 16 July 2024, from 14:00 to 16:00, at the Irish College Leuven’s Auditorium and online, followed by a cocktail reception.
The RLT Academy is launching a comprehensive set of policy recommendations, developed by established experts in the nuclear medicine field, to advance the adoption of RLT by addressing critical barriers to its implementation.
You can find the Save the Date attached to this email; the agenda will be sent shortly. Following the event, a networking reception will be held.
This is a unique opportunity to network, share ideas, and be part of a community that is shaping the future of cancer care through this breakthrough treatment across Europe. We would be delighted to see you there!
To register for this event either in-person or online, please CLICK HERE.
Kind regards,
Marietta on behalf of the RLT Academy Secretariat
Register here
Join us for a groundbreaking event as we mark the end of the first edition of the RLT Academy Project – by launching a set of policy recommendations to present to policymakers the current challenges and potential solutions for improving RLTs uptake by healthcare professionals and healthcare national systems.
Radioligand therapy (RLT) is an innovative type of nuclear medicine that targets markers on tumor cells or their microenvironment, with the goal of delivering the treatment mostly to the affected tumor cells, while limiting unwanted effects on healthy cells.
Bringing together established experts in the medical fields relevant to RLT, the RLT Academy is launching a set of policy recommendations to advise policymakers on overcoming barriers to RLT adoption.
Ensuring proper patient access to RLT in Europe requires addressing barriers such as healthcare infrastructure, regulatory contexts, and stakeholder cooperation from regional to European levels. These policy recommendations will build on best practices from the project and outline concrete actions for policymakers to take.
Please join us for this unique gathering to promote cutting-edge expertise in nuclear medicine and advanced Radioligand Therapy (RLT) for cancer care.
Consortium Leader
Project Management
Full Partners Associate Partners
POLICY RECOMMENDATIONS Launch Event 16 July 2024 Irish College Leuven’s Grand Auditorium/Online 14:00 - 16:00, followed by a cocktail reception
Register here
Join us for a groundbreaking event as we mark the end of the first edition of the RLT Academy Project – by launching a set of policy recommendations to present to policymakers the current challenges and potential solutions for improving RLTs uptake by healthcare professionals and healthcare national systems.
Radioligand therapy (RLT) is an innovative type of nuclear medicine that targets markers on tumor cells or their microenvironment, with the goal of delivering the treatment mostly to the affected tumor cells, while limiting unwanted effects on healthy cells.
Bringing together established experts in the medical fields relevant to RLT, the RLT Academy is launching a set of policy recommendations to advise policymakers on overcoming barriers to RLT adoption.
Ensuring proper patient access to RLT in Europe requires addressing barriers such as healthcare infrastructure, regulatory contexts, and stakeholder cooperation from regional to European levels. These policy recommendations will build on best practices from the project and outline concrete actions for policymakers to take.
Please join us for this unique gathering to promote cutting-edge expertise in nuclear medicine and advanced Radioligand Therapy (RLT) for cancer care.
Consortium Leader
Project Management
Full Partners Associate Partners
POLICY RECOMMENDATIONS Launch Event 16 July 2024 Irish College Leuven’s Grand Auditorium/Online 14:00 - 16:00, followed by a cocktail reception